By targeting the miR-3aa-5p/XBP1 axis, sEV lncRNA SNHG7 inhibits high glucose induced endothelial mesenchymal transition and tube formation and impairs the pathogenesis of diabetic retinopathy [163]. Here, XBP1 is linked to diabetic retinopathy.